Lenskart IPO and Groww IPO are attracting attention, with Lenskart concluding its subscription and Groww starting its process ...

In a world increasingly driven by sustainability, precision, and intelligent automation, Chinese entrepreneur Minglu Chen ...

NurExone’s U.S. subsidiary, Exo-Top Inc., is advancing plans for the establishment of a GMP-compliant facility dedicated to naive exosome production. The Company believes participation in ARMI’s ...

FDA recently issued the draft guidance, Quality Management System Information for Certain Premarket Submission Reviews. The guidance is designed ...

MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid ® Newly commissioned facility marks a ...

Researchers from IIT Madras and Ohio State University have developed an AI framework called PURE that can quickly generate drug-like molecules suitable for real-world synthesis. This innovation aims ...

MediWound (MDWD) announced the successful completion of the commissioning process for its expanded GMP manufacturing facility in Yavne, Israel.

Lumen Biosciences Brian Finrow breaks down Chinas biotech playbook and explores ways the U.S. can adapt it for its own continued success.

Pharmaust Limited ( ($AU:NUZ) ) has provided an update. Neurizon Therapeutics Limited has achieved significant milestones, including the FDA ...

Ajinomoto Bio-Pharma Services and Olon S.p.A. have entered into a strategic partnership to deliver drug substance manufacturing services.

Bioconjugation capability will complement commercial payload, linker and monoclonal antibodies services ...

AI refers to a machine-based system and ML refers to a set of techniques that can be used to train AI algorithms (2) so ML ...